HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael F La Fountaine Selected Research

LDL Cholesterol

7/2015Lipoprotein heterogeneity in persons with Spinal Cord Injury: a model of prolonged sitting and restricted physical activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael F La Fountaine Research Topics

Disease

16Spinal Cord Injuries (Spinal Cord Injury)
08/2020 - 01/2011
4Cardiovascular Diseases (Cardiovascular Disease)
11/2019 - 07/2015
3Insulin Resistance
07/2021 - 07/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2018
1Craniocerebral Trauma (Head Injury)
01/2016
1Quadriplegia (Spastic Quadriplegia)
01/2009

Drug/Important Bio-Agent (IBA)

6Triglycerides (Triacylglycerol)IBA
07/2021 - 01/2017
4Testosterone (Sustanon)FDA Link
01/2015 - 01/2011
3LipidsIBA
07/2021 - 07/2015
3HDL CholesterolIBA
07/2021 - 07/2015
3Lipoproteins (Lipoprotein)IBA
01/2020 - 07/2015
3Insulin (Novolin)FDA Link
01/2017 - 02/2013
2Fenofibrate (CiL)FDA LinkGeneric
01/2020 - 11/2019
2HDL LipoproteinsIBA
11/2018 - 11/2018
1Glucose (Dextrose)FDA LinkGeneric
07/2021
1Biomarkers (Surrogate Marker)IBA
07/2021
1DenosumabFDA Link
08/2020
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2018
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2016
1LDL CholesterolIBA
07/2015
1oxidized low density lipoproteinIBA
07/2015
1Zoledronic Acid (Zometa)FDA Link
07/2015
1BaclofenFDA LinkGeneric
09/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2013
1Nitric Oxide Synthase (NO Synthase)IBA
01/2009

Therapy/Procedure

4Therapeutics
01/2020 - 01/2013